Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senator-elect Wyden will add another moderate FDA reformer to Senate; seeking Finance or Labor seat.

Executive Summary

SENATOR-ELECT WYDEN WILL PURSUE FDA REFORM and other health related issues from his new Senate seat. Wyden (D-Ore.) will fill the seat of retired Sen. Packwood (R) following his victory in a Jan. 30 special election. Wyden's term runs through 1998. In his 15 years in the House, Wyden participated in numerous FDA and pharmaceutical industry debates. Most recently, he introduced the first comprehensive FDA reform bill in 1995.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS027608

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel